Cleared Traditional

K955793 - IL BGGE BLOOD GAS WITH GLUCOSE SYSTEM

K955793 is an FDA 510(k) clearance for IL BGGE BLOOD GAS WITH GLUCOSE SYSTEM, manufactured by Instrumentation Laboratory CO. The device is a Class 2 Chemistry device with product code CHL cleared through the Traditional 510(k) pathway after a 54-day FDA review.

K955793 · Instrumentation Laboratory CO · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1996
Decision
54d
Days
Class 2
Risk

K955793 is an FDA 510(k) clearance for the IL BGGE BLOOD GAS WITH GLUCOSE SYSTEM. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on February 14, 1996 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Instrumentation Laboratory CO devices

FDA 510(k) Submission Details - K955793

510(k) Number K955793 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 1995
Decision Date February 14, 1996
Days to Decision 54 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 88d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CHL Device Classification - Class 2, Special Controls

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 157
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K955793.
CIBA CORNING 400 SYSTEM
K961657 · Ciba Corning Diagnostics Corp. · Jun 1996
CIBA CORNING 348 SYSTEM
K962021 · Ciba Corning Diagnostics Corp. · Jun 1996
AVL OPTI 1 PH/BLOOD GAS ANALYZER
K961161 · Avl Scientific Corp. · Apr 1996
STAT PROFILE ULTRA 11 ANALYZER (MODIFICATION)
K954711 · Nova Biomedical Corp. · Nov 1995
ABL SYSTEM 625, 615, 605
K954612 · Radiometer America, Inc. · Nov 1995
ABL5 BLOOD GAS SYSTEM
K943882 · Radiometer America, Inc. · Mar 1995